120 related articles for article (PubMed ID: 3042579)
1. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
Glaser B; Zoghlin G; Pienta K; Vinik AI
Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal increase in pancreatic polypeptide in the secretin-provocation test: hypoglycemia-induced?].
Wirth HP; Eberle C; Gautschi K; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):735-9. PubMed ID: 7740287
[TBL] [Abstract][Full Text] [Related]
3. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man.
Seymour NE; Brunicardi FC; Chaiken RL; Lebovitz HE; Chance RE; Gingerich RL; Elahi D; Andersen DK
Surgery; 1988 Aug; 104(2):119-29. PubMed ID: 3041640
[TBL] [Abstract][Full Text] [Related]
4. Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
Lassmann V; Cabrerizzo Garcia L; Vialettes B; Vague P
Horm Metab Res; 1985 Dec; 17(12):663-6. PubMed ID: 3002934
[TBL] [Abstract][Full Text] [Related]
5. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
[TBL] [Abstract][Full Text] [Related]
6. Hyperfunction of the entero-PP axis in non-insulin dependent diabetes mellitus.
Tsuda K; Seino Y; Mori K; Seino S; Takemura J; Kuzuya H; Imura H
Horm Metab Res; 1983 Dec; 15(12):581-5. PubMed ID: 6363240
[TBL] [Abstract][Full Text] [Related]
7. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.
Bagdade JD; Bierman EL; Porte D
J Clin Invest; 1967 Oct; 46(10):1549-57. PubMed ID: 6061732
[TBL] [Abstract][Full Text] [Related]
8. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Sotos J
J Clin Endocrinol Metab; 1981 Jun; 52(6):1264-6. PubMed ID: 7014602
[TBL] [Abstract][Full Text] [Related]
9. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
García Pascual IJ; González Ruiz JM
An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
[TBL] [Abstract][Full Text] [Related]
10. Responses of vasoactive intestinal polypeptide, secretin, and human pancreatic polypeptide to glucose during fasting.
Oktedalen O; Opstad PK; Jorde R; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1984 Jan; 19(1):59-64. PubMed ID: 6710078
[TBL] [Abstract][Full Text] [Related]
11. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
12. Changes of early insulin responses to glucose in obese subjects with normal and impaired carbohydrate tolerance.
Ratzmann KP; Schulz B; Witt S; Heinke P; Ziegler M
Endokrinologie; 1981 Oct; 78(1):89-98. PubMed ID: 7032897
[TBL] [Abstract][Full Text] [Related]
13. [Impaired glucose tolerance in obesity in children and adolescents].
Ripamonti G; De Medici C; Guzzaloni G; Moreni G; Ardizzi A; Morabito F
Minerva Med; 1991 Jun; 82(6):345-8. PubMed ID: 2067706
[TBL] [Abstract][Full Text] [Related]
14. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Dixon K
J Clin Endocrinol Metab; 1983 Nov; 57(5):1074-80. PubMed ID: 6352724
[TBL] [Abstract][Full Text] [Related]
16. Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity.
Jorde R; Burhol PG
Int J Obes; 1984; 8(5):393-7. PubMed ID: 6394520
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of secretin on pancreatic polypeptide in diabetic patients.
Toyota T; Koizumi M; Kai Y; Miura M; Umetsu M; Suzuki S; Goto Y
Endocrinol Jpn; 1980 Apr; 27(2):145-7. PubMed ID: 6997022
[TBL] [Abstract][Full Text] [Related]
18. Plasma human pancreatic polypeptide response in chronic pancreatitis.
Matsumoto M; Wakasugi H; Ibayashi H
Gastroenterol Jpn; 1982; 17(1):25-30. PubMed ID: 7042449
[TBL] [Abstract][Full Text] [Related]
19. Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity.
Pieramico O; Malfertheiner P; Nelson DK; Glasbrenner B; Ditschuneit H
Int J Obes; 1990 Dec; 14(12):1005-11. PubMed ID: 2086493
[TBL] [Abstract][Full Text] [Related]
20. [Raised plasma glucagon levels in obesity (author's transl)].
Starke A; Starke G; Jörgens V; Berger M; Zimmermann H
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1125-8. PubMed ID: 7084079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
